Patents by Inventor Daniel Eduardo Groszmann

Daniel Eduardo Groszmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12109389
    Abstract: Fluid path assemblies for drug delivery devices and methods of establishing a fluid flow path for drug delivery devices are described that include a needle shield valve member that couples to a reservoir having a needle mounted thereto. The needle shield valve member includes an internal barrier that protects the needle and/or contains a drug within the reservoir until activation of the drug delivery device. Upon activation, there is relative movement between the reservoir and needle shield valve member until the needle pierces the barrier to establish a fluid flow path from the reservoir through the needle shield valve member.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: October 8, 2024
    Assignee: AMGEN INC.
    Inventors: Matthew Wayne Janke, Sudeshna Dutta Ray, Scott R. Gibson, Daniel Eduardo Groszmann, Wael Mismar, Mehran Mojarrad, Robert Allen Dees, Paul Daniel Faucher
  • Patent number: 12042642
    Abstract: Drug delivery devices are described that include an escapement activation assembly. The escapement activation assembly includes a slide having a plurality of pallet engagement portions and a switch engagement portion and a pallet having a plurality of slide engagement portions. A drive is coupled to the pallet to cause the pallet to move relative to the slide to move the plurality of slide engagement portions into and out of engagement with the plurality of pallet engagement portions to allow the slide to move along a path within the drug delivery device. Movement of the slide can cause the switch engagement portion to move out of engagement with an activation trigger of a mechanism of the drug delivery device.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: July 23, 2024
    Assignee: AMGEN INC.
    Inventors: Sudeshna Dutta Ray, Scott Robert Gibson, Daniel Eduardo Groszmann, Mehran Mojarrad, Andrew James Carlson, Lee Gordon Macklem, Mikhail Tikh
  • Publication number: 20240066206
    Abstract: A drug delivery device includes a housing, a container disposed in the housing, an activation mechanism, a needle assembly, and a temperature indicator. The housing defines an inner volume and includes at least one opening. The container contains a medicament which is urged out of the container by the activation mechanism. The needle assembly has a needle and/or a cannula to deliver the medicament from the container. The temperature indicator is operably coupled with the outer surface of the container and is responsive to a change in temperature of the container.
    Type: Application
    Filed: September 29, 2020
    Publication date: February 29, 2024
    Inventors: Heejin Lee, Daniel Eduardo Groszmann, Sheldon B. Moberg, Mohammad Bonakdar, Rasmus Ohlenschlaeger
  • Patent number: 11890450
    Abstract: A drug delivery device includes a housing defining a shell and an inner volume, a container, a drive mechanism, a needle assembly, a fluid flow connection, and a backflow prevention mechanism. The container has an inner volume to contain a medicament to be administered to a user. The drive mechanism is at least partially disposed within the housing and exerts a force to urge the medicament out the container. The fluid flow connection is coupled to the container and the needle assembly and allows the medicament to flow from the container to the needle assembly to be administered. The backflow prevention mechanism is associated with at least one of the container, the fluid flow connection, or the needle assembly and includes at least one flow restrictor to restrict a fluid from flowing from the needle assembly to the container.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: February 6, 2024
    Assignee: AMGEN INC.
    Inventors: Lawrence Scott Ring, Tohid Pirbodaghi, Samin Akbari, Daniel Eduardo Groszmann, Mehran Mojarrad, Mark Gordon, Mikhail Tikh, Jimmie L. Ward, Scott R. Gibson, Sheldon B. Moberg, Joshua Tamsky, Paul Faucher, Jeff Lind
  • Patent number: 11766519
    Abstract: A flexible plunger rod, drug delivery mechanism, drug delivery device, and methods are described that utilize the flexible plunger rod perform drug delivery operations. In embodiments, the flexible plunger rod can be stored in a curved configuration to thereby reduce a footprint of the drug delivery mechanism and device.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: September 26, 2023
    Assignee: AMGEN INC.
    Inventors: Sudeshna Dutta Ray, Scott R. Gibson, Daniel Eduardo Groszmann, Mehran Mojarrad, Robert Allen Dees, Jonathan Dean Johnson, Antonio S. Murcia
  • Publication number: 20230173198
    Abstract: Drug delivery member insertion depth sensing assemblies, drug delivery devices, and methods for determining an insertion depth of a drug delivery member are disclosed. The sensing assemblies can include electrical sensing assemblies with direct or indirect measurement components or optical sensing assemblies with one or more light sources and one or more photodiodes. A controller of the sensing assemblies can receive data associated with the drug delivery member in an insertion position. The data can then be correlated to an insertion depth of the drug delivery member.
    Type: Application
    Filed: February 8, 2021
    Publication date: June 8, 2023
    Inventors: Mohammad Bonakdar, Daniel Eduardo Groszmann, Heejin Lee, Leonela Sabrina Vega Loaisa
  • Patent number: 11660391
    Abstract: Systems and methods for injecting a drug and detecting tissue induced back pressure are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, an administration member connected or connectable in fluid communication with the reservoir, a drive assembly, and a pressure sensor. The administration member may be configured for insertion into and subsequently retraction from a patient. The drive assembly may be configured to urge the drug from the reservoir to deliver a dose of the drug to the patient via the administration member. The pressure sensor may be configured to detect tissue back pressure during use of the drug delivery system, including after dose completion and prior to retraction of the administration member. The drug delivery system may be controlled in a manner that accounts for the tissue back pressure measurement.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: May 30, 2023
    Assignee: AMGEN INC.
    Inventors: Daniel Eduardo Groszmann, Scott Robert Gibson
  • Patent number: 11534547
    Abstract: Systems and methods for drug delivery with pressure sensitive control are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, a drug delivery device coupled to the reservoir to deliver the drug from the reservoir to a patient, a pressure sensor, an output device, and a controller. The controller may be configured to determine if the drug delivery device has completed delivering a dose of the drug to the patient, and if delivery of the dose of the drug is complete, to measure tissue back pressure using the pressure sensor. Subsequently, the controller may be configured to determine if the tissue back pressure is below a first predetermined value, and if so, control the output device at least once and/or control a mechanism to retract an administration member from the patient.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: December 27, 2022
    Assignee: AMGEN INC.
    Inventors: Daniel Eduardo Groszmann, Scott Robert Gibson
  • Publication number: 20220047808
    Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.
    Type: Application
    Filed: June 28, 2021
    Publication date: February 17, 2022
    Inventors: Scott Robert GIBSON, Sudeshna DUTTA RAY, Daniel Eduardo GROSZMANN, Mehran MOJARRAD, Nathan Thomas BALCOM, Alejandro CAMPILLO-AGUSTI, Alan D. PAYNE, Lawrence Scott RING
  • Patent number: 11083840
    Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: August 10, 2021
    Assignee: AMGEN INC.
    Inventors: Scott Robert Gibson, Sudeshna Dutta Ray, Daniel Eduardo Groszmann, Mehran Mojarrad, Nathan Thomas Balcom, Alejandro Campillo-Agusti, Alan D. Payne, Lawrence Scott Ring
  • Publication number: 20210228811
    Abstract: Drug delivery devices are described that include an escapement activation assembly. The escapement activation assembly includes a slide having a plurality of pallet engagement portions and a switch engagement portion and a pallet having a plurality of slide engagement portions. A drive is coupled to the pallet to cause the pallet to move relative to the slide to move the plurality of slide engagement portions into and out of engagement with the plurality of pallet engagement portions to allow the slide to move along a path within the drug delivery device. Movement of the slide can cause the switch engagement portion to move out of engagement with an activation trigger of a mechanism of the drug delivery device.
    Type: Application
    Filed: September 17, 2019
    Publication date: July 29, 2021
    Inventors: Sudeshna Dutta Ray, Scott Robert Gibson, Daniel Eduardo Groszmann, Mehran Mojarrad, Andrew James Carlson, Lee Gordon Macklem, Mikhail Tikh
  • Publication number: 20210228797
    Abstract: Fluid path assemblies for drug delivery devices and methods of establishing a fluid flow path for drug delivery devices are described that include a needle shield valve member that couples to a reservoir having a needle mounted thereto. The needle shield valve member includes an internal barrier that protects the needle and/or contains a drug within the reservoir until activation of the drug delivery device. Upon activation, there is relative movement between the reservoir and needle shield valve member until the needle pierces the barrier to establish a fluid flow path from the reservoir through the needle shield valve member.
    Type: Application
    Filed: July 12, 2019
    Publication date: July 29, 2021
    Inventors: Matthew Wayne Janke, Sudeshna Dutta Ray, Scott R. Gibson, Daniel Eduardo Groszmann, Wael Mismar, Mehran Mojarrad, Robert Allen Dees, Paul Daniel Faucher
  • Publication number: 20210060259
    Abstract: A flexible plunger rod, drug delivery mechanism, drug delivery device, and methods are described that utilize the flexible plunger rod perform drug delivery operations. In embodiments, the flexible plunger rod can be stored in a curved configuration to thereby reduce a footprint of the drug delivery mechanism and device.
    Type: Application
    Filed: January 17, 2019
    Publication date: March 4, 2021
    Applicant: AMGEN INC.
    Inventors: Sudeshna Dutta Ray, Scott R. Gibson, Daniel Eduardo Groszmann, Mehran Mojarrad, Robert Allen Dees, Jonathan Dean Johnson, Antonio S. Murcia
  • Publication number: 20200261648
    Abstract: A drug delivery device is provided that includes an on-board controller to determine when proper placement on the patient's body has occurred as well as an amount of drug delivered to the patient. The controller can also be used to determine if and when the proper placement has been disturbed during drug delivery and/or if less than a full dose of the drug has been dispensed.
    Type: Application
    Filed: October 4, 2018
    Publication date: August 20, 2020
    Inventors: Daniel Eduardo Groszmann, Scott Robert Gibson
  • Publication number: 20200238006
    Abstract: Systems and methods for injecting a drug and detecting tissue induced back pressure are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, an administration member connected or connectable in fluid communication with the reservoir, a drive assembly, and a pressure sensor. The administration member may be configured for insertion into and subsequently retraction from a patient. The drive assembly may be configured to urge the drug from the reservoir to deliver a dose of the drug to the patient via the administration member. The pressure sensor may be configured to detect tissue back pressure during use of the drug delivery system, including after dose completion and prior to retraction of the administration member. The drug delivery system may be controlled in a manner that accounts for the tissue back pressure measurement.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 30, 2020
    Inventors: Daniel Eduardo Groszmann, Scott Robert Gibson
  • Publication number: 20200238005
    Abstract: Systems and methods for drug delivery with pressure sensitive control are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, a drug delivery device coupled to the reservoir to deliver the drug from the reservoir to a patient, a pressure sensor, an output device, and a controller. The controller may be configured to determine if the drug delivery device has completed delivering a dose of the drug to the patient, and if delivery of the dose of the drug is complete, to measure tissue back pressure using the pressure sensor. Subsequently, the controller may be configured to determine if the tissue back pressure is below a first predetermined value, and if so, control the output device at least once and/or control a mechanism to retract an administration member from the patient.
    Type: Application
    Filed: December 23, 2019
    Publication date: July 30, 2020
    Inventors: Daniel Eduardo Groszmann, Scott Robert Gibson
  • Publication number: 20190365987
    Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.
    Type: Application
    Filed: June 1, 2018
    Publication date: December 5, 2019
    Inventors: Scott Robert Gibson, Sudeshna Dutta Ray, Daniel Eduardo Groszmann, Mehran Mojarrad, Nathan Thomas Balcom, Alejandro Campillo-Agusti, Alan D. Payne, Lawrence Scott Ring
  • Publication number: 20190275241
    Abstract: A drug delivery device includes a housing defining a shell and an inner volume, a container, a drive mechanism, a needle assembly, a fluid flow connection, and a backflow prevention mechanism. The container has an inner volume to contain a medicament to be administered to a user. The drive mechanism is at least partially disposed within the housing and exerts a force to urge the medicament out the container. The fluid flow connection is coupled to the container and the needle assembly and allows the medicament to flow from the container to the needle assembly to be administered. The backflow prevention mechanism is associated with at least one of the container, the fluid flow connection, or the needle assembly and includes at least one flow restrictor to restrict a fluid from flowing from the needle assembly to the container.
    Type: Application
    Filed: March 8, 2019
    Publication date: September 12, 2019
    Inventors: Lawrence S. Ring, Tohid Pirbodaghi, Samin Akbari, Daniel Eduardo Groszmann, Mehran Mojarrad, Mark Gordon, Mikhail Tikh, Jimmie L. Ward, Scott R. Gibson, Sheldon B. Moberg, Joshua Tamsky, Paul Faucher
  • Patent number: 10398393
    Abstract: An interventional device configured for placement in or near an internal organ or tissue is provided. The interventional device includes a reference portion having three or more sensor elements. In one implementation, the interventional device and associated sensor elements provide dynamic referencing of the internal organ, tissue or associated vasculature after registration of the sensor data with images and/or volumetric representations of the internal organ or tissue.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: September 3, 2019
    Assignee: STRYKER EUROPEAN HOLDINGS I, LLC
    Inventors: Daniel Eduardo Groszmann, Michel Francois Grimaud, Yves Lucien Trousset
  • Patent number: D810096
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: February 13, 2018
    Assignee: General Electric Company
    Inventors: Daniel Eduardo Groszmann, Laurent Jacques Node-Langlois, Taylor Braun-Jones